Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Legislative leaders say the decision whether to renew Montana’s Medicaid expansion program this year will loom over behavioral health spending and hospital regulation, among other…
Have sobering studies on alcohol caused physicians to drink less themselves or changed the way doctors counsel patients on booze? The answer is complicated.
By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits.
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — For many, coffee is a beloved morning ritual, fueling the day ahead. But what if the time you…
Low back pain covers a spectrum of different types of pain (eg, nociceptive, neuropathic and nociplastic, or non-specific) that frequently overlap. The elements comprising the…
Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure worried patients about their cancer risk…
It might be tempting to try to pop hidradenitis suppurativa cysts, but it’s critical to resist the temptation. A dermatologist explains how they’re not normal…
Hospital-at-home programs are rapidly transforming American healthcare delivery, providing a transformational model of care that combines convenience, quality and cost-efficiency. While some current opinion …
Employee healthcare navigation company Transcarent plans to acquire health benefits platform Accolade in a deal valued at $621 million, the company announced Wednesday. | Employee…
To the Editor I appreciate the call by Brender et al1 to thoughtfully consider the place of artificial intelligence (AI) in serious illness conversations.1 As…